ENvue Medical secures notice of allowance from USPTO

ENvue Medical (FEED) announced that the United States Patent and Trademark Office has issued a notice of allowance for a patent covering a novel drug delivery system utilizing the company’s proprietary surface acoustic wave technology to enhance transdermal delivery of cannabinoid-based therapeutics. The allowed claims provide broad intellectual property protection across multiple components of the combined SAW ultrasound and cannabinoid transdermal delivery system, including transdermal patch configurations, portable SAW-generating platforms, and methods shown to produce synergistic enhancement in cannabinoid absorption through the skin compared to administration via the transdermal patch alone.